Published in J Virol Methods on June 01, 2001
Real-time PCR in virology. Nucleic Acids Res (2002) 6.71
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol (2002) 4.55
Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol (2007) 1.82
Real-time PCR for detection and quantitation of leishmania in mouse tissues. J Clin Microbiol (2002) 1.63
Diagnosis of hepatitis a virus infection: a molecular approach. Clin Microbiol Rev (2006) 1.42
DNA hybridization assays using metal-enhanced fluorescence. Biochem Biophys Res Commun (2003) 1.41
Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins. J Gen Virol (2006) 1.39
Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci (2006) 1.19
Advances in surface-enhanced fluorescence. J Fluoresc (2004) 1.18
Use of the MagNA pure LC automated nucleic acid extraction system followed by real-time reverse transcription-PCR for ultrasensitive quantitation of hepatitis C virus RNA. J Clin Microbiol (2004) 1.16
Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J Virol (2004) 1.14
Quantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR. J Clin Microbiol (2002) 1.14
Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo. J Gen Virol (2004) 1.03
Variable ratio of hepatitis C virus RNA to viral core antigen in patient sera. J Clin Microbiol (2004) 1.00
Prospective follow-up of patients with acute hepatitis C virus infection in Brazil. Clin Infect Dis (2010) 0.92
Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection. J Gen Virol (2010) 0.89
Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells. J Virol (2013) 0.89
Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A. J Virol (2012) 0.86
Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus. PLoS One (2008) 0.86
Hepatitis C lipo-Viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell. PLoS One (2007) 0.85
Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes. PLoS One (2011) 0.83
A highly conserved G-rich consensus sequence in hepatitis C virus core gene represents a new anti-hepatitis C target. Sci Adv (2016) 0.83
Detection and quantification of hepatitis B virus DNA by SYBR green real-time polymerase chain reaction. Eur J Clin Microbiol Infect Dis (2007) 0.82
Recombinase polymerase amplification as a promising tool in hepatitis C virus diagnosis. World J Hepatol (2014) 0.81
Lack of variant specific CD8+ T-cell response against mutant and pre-existing variants leads to outgrowth of particular clones in acute hepatitis C. Virol J (2013) 0.77
Antiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus. Iran J Pharm Res (2016) 0.75
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol (2002) 4.55
An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol (2000) 4.05
Hepatitis C virus infection protein network. Mol Syst Biol (2008) 2.91
CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. J Infect Dis (2000) 2.34
Mice lacking the MHC class II-associated invariant chain. Cell (1993) 2.30
Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol (1999) 2.29
Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature (1990) 2.11
Evidence for a viral superantigen in humans. Nature (1992) 2.01
Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A (1997) 1.97
High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol (2001) 1.94
Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005-2007. Clin Microbiol Infect (2009) 1.76
Percutaneous gastrostomy with fluoroscopic guidance: single-center experience in 500 consecutive cancer patients. Radiology (1999) 1.70
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat (2005) 1.64
Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity. J Hepatol (2000) 1.59
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc Natl Acad Sci U S A (1998) 1.50
[Maternofetal disseminated candidiasis and high-grade prematurity]. Arch Pediatr (1997) 1.42
The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group. Diabetes Care (1996) 1.41
Abdominal tuberculosis involving hepatic hilar lymph nodes. A cause of portal vein thrombosis and portal hypertension. J Clin Gastroenterol (1997) 1.39
CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. AIDS (2001) 1.38
Serotyping and esterase typing for analysis of Listeria monocytogenes populations recovered from foodstuffs and from human patients with listeriosis in Belgium. J Clin Microbiol (1996) 1.38
ApoE deficiency compromises the blood brain barrier especially after injury. Mol Med (2001) 1.38
Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood (2001) 1.33
A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing. Nature (1987) 1.26
Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver. J Biol Chem (1999) 1.26
Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci U S A (2001) 1.25
Incarceration of the appendix complicating a uterine perforation following surgical abortion: CT aspects. Emerg Radiol (2008) 1.23
Comparison of four methods for early detection of experimental Trichinella spiralis infections in pigs. Vet Parasitol (1981) 1.21
Transcription of RNA templates by T7 RNA polymerase. Nucleic Acids Res (1998) 1.19
Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation. Nature (1984) 1.19
Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J Immunol (2001) 1.17
Phylogeny of a novel family of human endogenous retrovirus sequences, HERV-W, in humans and other primates. AIDS Res Hum Retroviruses (1999) 1.17
Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family. AIDS Res Hum Retroviruses (2000) 1.16
Continuous RT-PCR using AMV-RT and Taq DNA polymerase: characterization and comparison to uncoupled procedures. Biotechniques (1995) 1.14
Enzyme-linked oligosorbent assay for detection of polymerase chain reaction-amplified human immunodeficiency virus type 1. J Clin Microbiol (1993) 1.13
Association of signal-regulatory proteins beta with KARAP/DAP-12. Eur J Immunol (2000) 1.13
Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology (1999) 1.12
Diagnostic performance of MRI for detection of intestinal fistulas in patients with complicated inflammatory bowel conditions. Eur Radiol (2007) 1.07
CD4 T cell tolerance to nuclear proteins induced by medullary thymic epithelium. Immunity (1996) 1.04
ViralORFeome: an integrated database to generate a versatile collection of viral ORFs. Nucleic Acids Res (2009) 1.04
MRI features of a pancreatic schwannoma. Clin Imaging (2005) 1.03
Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol (2000) 1.03
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse. Leukemia (2013) 1.01
Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production. J Exp Med (1997) 1.01
Listeria monocytogenes possesses adhesins for fibronectin. Infect Immun (1999) 1.00
[Environmental factors in the etiology of Parkinson's disease]. Can J Neurol Sci (1990) 1.00
Mutational spectrometry without phenotypic selection: human mitochondrial DNA. Nucleic Acids Res (1997) 1.00
MR monitoring of tumour thermal therapy. MAGMA (2001) 0.99
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol (2007) 0.97
HLA DR, DQ, and DP antigen expression in rheumatoid synovial cells: a biochemical and quantitative study. J Immunol (1987) 0.97
Use of a TT virus ORF1 recombinant protein to detect anti-TT virus antibodies in human sera. J Gen Virol (2000) 0.97
In vivo regulation of von willebrand factor synthesis: von Willebrand factor production in endothelial cells after lung transplantation between normal pigs and von Willebrand factor-deficient pigs. Arterioscler Thromb Vasc Biol (1999) 0.96
Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation. Leukemia (2011) 0.96
Flow cytometric sorting and biochemical characterization of the late endosomal rab7-containing compartment. Electrophoresis (1997) 0.96
Platelet functions and haemostasis parameters in pigs: absence of side effects of a procedure of general anaesthesia. Thromb Res (1996) 0.95
Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor. J Biol Chem (1997) 0.95
New types of primers (stair primers) for PCR amplification of the variable V3 region of the human immunodeficiency virus. J Virol Methods (1996) 0.95
Heavy elements in urinary stones. Urol Res (2007) 0.94
System-level comparison of protein-protein interactions between viruses and the human type I interferon system network. J Proteome Res (2010) 0.94
Selective increased presentation of type II collagen by leupeptin. Int Immunol (1997) 0.94
[Radiologic aspects of the complications of duodenal diverticula]. J Radiol (1999) 0.94
Clinical and epidemiological aspects of Listeriosis in Belgium, 1985-1990. Zentralbl Bakteriol (1991) 0.93
Construction and expression of a modular gene encoding bacteriophage T7 RNA polymerase. Gene (1997) 0.93
Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease. Leukemia (2012) 0.92
Quantitation of human immunodeficiency virus type 1 DNA by two PCR procedures coupled with enzyme-linked oligosorbent assay. J Clin Microbiol (1995) 0.92
Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection. Hepatology (1990) 0.92
Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon. J Med Virol (1997) 0.92
Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study. Arterioscler Thromb Vasc Biol (2001) 0.91
Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity. Br J Pharmacol (1996) 0.91
Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alpha. J Viral Hepat (1998) 0.91
Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity. Diabetes Care (1998) 0.90
Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV. J Hepatol (1986) 0.90
Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol (2000) 0.90
An interdisciplinary approach to controlling chikungunya outbreaks on French islands in the south-west Indian ocean. Med Trop (Mars) (2012) 0.90
Mutational spectrometry: means and ends. Prog Nucleic Acid Res Mol Biol (1994) 0.90
Modulation of HLA-G antigens expression in myelomonocytic cells. Hum Immunol (2000) 0.90
Polysialylated-neural cell adhesion molecule expression in rat pituitary transplantable tumors (spontaneous mammotropic transplantable tumor in Wistar-Furth rats) is related to growth rate and malignancy. Cancer Res (2000) 0.89
[Imaging of inflammatory pseudotumors of the liver]. J Radiol (2007) 0.89
Cyclin dependent kinase inhibitors prevent apoptosis of postmitotic mouse motoneurons. Life Sci (2006) 0.89
Linear B-cell epitopes of the major core protein of human immunodeficiency virus types 1 and 2. J Virol (1990) 0.89
Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases. Leukemia (2008) 0.89
Selectivity of the major histocompatibility complex class II presentation pathway of cortical thymic epithelial cell lines. Eur J Immunol (1997) 0.89
Sporadic case of listeriosis associated with the consumption of a Listeria monocytogenes-contaminated 'Camembert' cheese. J Infect (1997) 0.88
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin. Leukemia (2009) 0.88
Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models. Blood (2001) 0.88
Infrequency of detection of particle-associated MSRV/HERV-W RNA in the synovial fluid of patients with rheumatoid arthritis. Rheumatology (Oxford) (2000) 0.88
Treatment with metformin of non-diabetic men with hypertension, hypertriglyceridaemia and central fat distribution: the BIGPRO 1.2 trial. Diabetes Metab Res Rev (2000) 0.87
Detection of human bocavirus 3 in China. Eur J Clin Microbiol Infect Dis (2011) 0.87
Hepatitis C: description of a highly sensitive method for clinical detection of viral RNA. J Virol Methods (1994) 0.86